June 1, 2022 - Commercialization of Novel Battery Technology: Richman Chemical Possesses Synthetic Expertise for Inorganic, Polymer, and MOF Target Compounds
July 22, 2021 - Hydrogels / Tetradecylphosphonic Acid (TDPA) Bulk Supply for the Electronics and Display Industries
November 3, 2020 - Full-Time Equivalents (FTE) are the flexible choice for on-going development
March 17, 2020 - As COVID-19 Disrupts Global Supply Chains, Look to Richman Chemical as your Reliable Domestic Custom Synthesis and Manufacturing Partner
February 6, 2020 - Key Raw Material Discontinued or Unavailable? Richman Chemical CAN Help! (Case Study Approach)
March 27, 2019 - Overseas Factory Shutdown? RCI Can Help
May 21, 2018 - Richman Chemical Inc: Celebrating 30 Years of Growth
May 1, 2017 - Method Development and Validation of Analytical Methods for Drug Development
December 2016 - A Case Study Approach to Licensing Chemistry-based Technologies
May 2016 - RCI's Chemistry Expertise Bolsters Intellectual Property and Litigation Claims
July 2015 - Technology Assessment Reports Evaluate the Commercial Feasibility of New Technologies and Recommend Optimal Commercialization Strategies
October 2014 - Custom Synthesis for Medical Device Markets
June 2014 - Four Factors to Consider First when Choosing Your Outsourcing Partner
March 2014 - Navigating the Valley of Death with Richman Chemical
January 2014 - Unique Custom Capabilities Meet Increased Demand for Inorganics
July 2013- Richman Chemical Develops New Supply of Trimethylene Carbonate
April 2013 - The Lean Startup: Commercialize or Capsize
February 2013 - When It Makes Sense to Outsource in the Drug Development & Commercialization Process: The Value of External Project Management